ID
int64
1
9.11k
age
float64
18
102
death
int64
0
1
sex
stringclasses
2 values
hospdead
int64
0
1
slos
int64
3
343
d.time
int64
3
2.03k
dzgroup
stringclasses
8 values
dzclass
stringclasses
4 values
num.co
int64
0
9
edu
float64
0
31
income
stringclasses
4 values
scoma
float64
0
100
charges
float64
1.17k
1.44M
totcst
float64
0
633k
totmcst
float64
-102.72
711k
avtisst
float64
1
83
race
stringclasses
5 values
sps
float64
0.2
99.2
aps
float64
0
143
surv2m
float64
0
0.97
surv6m
float64
0
0.95
hday
int64
1
148
diabetes
int64
0
1
dementia
int64
0
1
ca
stringclasses
3 values
prg2m
float64
0
1
prg6m
float64
0
1
dnr
stringclasses
3 values
dnrday
float64
-88
285
meanbp
float64
0
195
wblc
float64
0
200
hrt
float64
0
300
resp
float64
0
90
temp
float64
31.7
41.7
pafi
float64
12
890
alb
float64
0.4
29
bili
float64
0.1
63
crea
float64
0.1
21.5
sod
float64
110
181
ph
float64
6.83
7.77
glucose
float64
0
1.09k
bun
float64
1
300
urine
float64
0
9k
adlp
float64
0
7
adls
float64
0
7
sfdm2
stringclasses
5 values
adlsc
float64
0
7.07
7,501
72.81897
1
male
0
9
346
CHF
COPD/CHF/Cirrhosis
5
6
under $11k
0
6,878
4,825.4375
5,418.42969
10
white
17.898438
10
0.826904
0.717896
1
1
0
yes
1
0.6
no dnr
9
47
31.796875
158
28
36.59375
354.8125
3.299805
3.199707
3.899902
136
7.349609
165
62
2,534
0
null
no(M2 and SIP pres)
0.494751
7,502
63.94498
0
male
0
5
535
CHF
COPD/CHF/Cirrhosis
3
12
$11-$25k
0
4,836
3,275.541
3,678.50977
12
white
16.398438
24
0.897949
0.827881
1
1
0
no
0.9
0.6
no dnr
5
141
8.898438
132
24
38.5
295.1875
3
0.699951
1.299805
137
7.529297
216
23
1,965
1
0
SIP>=30
0
7,503
73.336
1
female
0
7
100
COPD
COPD/CHF/Cirrhosis
4
null
under $11k
0
10,886
6,786.2812
7,725.66797
11
black
29.597656
39
0.584961
0.391968
1
0
0
yes
0.5
0.5
no dnr
7
114
19
111
40
35.79688
190
3
0.699951
2.799805
144
7.40918
204
50
910
null
0
adl>=4 (>=5 if sur)
0
7,504
61.72198
1
male
0
4
93
COPD
COPD/CHF/Cirrhosis
3
10
under $11k
0
5,234
3,014.6914
3,693.28906
16
white
13.699219
18
0.924927
0.872925
1
0
0
no
0.8
0.7
no dnr
4
122
17.796875
120
36
38.39844
134
2.5
0.5
0.299988
145
7.379883
74
14
1,979
0
null
no(M2 and SIP pres)
0.494751
7,505
68.07098
0
male
0
15
531
Cirrhosis
COPD/CHF/Cirrhosis
6
9
under $11k
0
47,397
31,747.0938
40,763.0312
41.333313
white
20.097656
35
0.738892
0.590942
1
0
0
no
0.3
0.1
no dnr
15
126
11.298828
120
32
38.89844
167.5
2.299805
4.599609
0.699951
142
7.519531
96
17
1,045
null
2
adl>=4 (>=5 if sur)
2
7,506
64.99896
0
male
0
15
531
ARF/MOSF w/Sepsis
ARF/MOSF
1
11
under $11k
0
40,531
25,163.0469
28,500.7656
28
white
30.796875
60
0.689941
0.5979
1
0
0
no
0.9
0.9
no dnr
15
123
15.398438
59
6
36.19531
293.3125
4.299805
0.599976
1.5
146
7.439453
202
24
4,240
null
1
no(M2 and SIP pres)
1
7,507
57.96298
1
male
1
13
13
Cirrhosis
COPD/CHF/Cirrhosis
3
12
$11-$25k
100
50,618
31,324.4531
37,703.9062
52.5
white
37.5
67
0.021
0.001
1
0
0
no
0.2
0.1
dnr after sadm
13
69
13.699219
107
28
37.5
185.6875
2.799805
0.399963
1.5
130
7.429688
119
26
7.5
null
2
<2 mo. follow-up
2
7,508
53.82599
0
female
0
10
530
COPD
COPD/CHF/Cirrhosis
0
10
$11-$25k
0
21,187
12,924.2812
14,137.7656
29.5
white
22.296875
39
0.887939
0.81189
1
0
0
no
0.8
0.7
no dnr
10
125
23.898438
107
34
36
260
3
1
0.699951
134
7.509766
156
16
1,685
0
4
null
4
7,509
26.91299
0
male
0
15
529
ARF/MOSF w/Sepsis
ARF/MOSF
2
10
$25-$50k
0
20,458
13,595.0078
15,301.2656
12.333328
white
21.5
31
0.919922
0.889893
1
0
0
no
0.8
0.89
no dnr
15
79
3.5
76
20
36.5
null
3
5.299805
1.099854
130
null
97
7
3,050
null
5
adl>=4 (>=5 if sur)
5
7,510
57.79599
0
male
0
40
528
ARF/MOSF w/Sepsis
ARF/MOSF
5
11
under $11k
100
114,737
75,503.9375
87,248
44.25
white
75.5
92
0
0
3
1
0
no
0.3
0.1
no dnr
40
111
13.298828
103
22
36
386
2.299805
0.599976
1.199951
133
7.469727
71
18
2,295
null
6
SIP>=30
6
7,511
65.94397
0
female
0
27
527
Coma
Coma
0
12
$11-$25k
94
86,330
55,693.9688
65,210.0938
32
white
24.597656
36
0.128998
0.081985
9
0
0
no
0.75
0.85
no dnr
27
67
11.898438
157
36
38.69531
97.5
1.799805
0.5
0.599976
133
7.529297
198
10
3,160
null
0
adl>=4 (>=5 if sur)
0
7,512
71.35394
1
male
0
8
350
Colon Cancer
Cancer
3
12
$11-$25k
0
5,664
4,086.1523
5,531.9375
7.5
white
16.296875
14
0.814941
0.601929
1
1
0
metastatic
0.1
0
no dnr
8
118
8.5
120
28
37.69531
306.625
2.5
14.699219
0.699951
145
7.489258
74
10
4,655
0
1
no(M2 and SIP pres)
1
7,513
39.15399
0
female
0
21
526
ARF/MOSF w/Sepsis
ARF/MOSF
3
12
under $11k
0
65,108
41,013.4688
47,491.8125
34
white
21.097656
16
0.902954
0.86792
1
0
0
no
0.7
0.7
no dnr
21
49
5.299805
68
20
35
null
3.199707
0.5
1.299805
143
null
159
58
1,220
null
7
null
7
7,514
63.211
1
male
1
12
12
Lung Cancer
Cancer
2
null
under $11k
0
13,598
9,065.5
12,148.6797
14.5
black
30.199219
37
0.371948
0.08699
1
0
0
metastatic
0.3
0.1
dnr after sadm
10
115
8.699219
80
28
36.39844
186.9375
4
1.799805
1.199951
139
7.40918
170
32
3,030
null
0
<2 mo. follow-up
0
7,515
58.53
1
male
0
3
155
Lung Cancer
Cancer
1
13
$11-$25k
0
4,163
0
0
null
black
18.597656
31
0.691895
0.401978
1
0
0
metastatic
1
1
no dnr
3
115
14.699219
67
42
39.39844
142
3.099609
7.599609
0.699951
142
7.429688
96
11
4,586
null
null
no(M2 and SIP pres)
2.467285
7,516
41.97098
1
female
1
7
7
ARF/MOSF w/Sepsis
ARF/MOSF
0
16
>$50k
0
28,025
17,503.9375
21,088.6406
47.5
white
23.296875
46
0.856934
0.807983
4
0
0
no
0.37
0.23
no dnr
7
87
7.299805
72
24
37.59375
null
null
null
0.899902
136
null
211
17
null
null
0
<2 mo. follow-up
0
7,517
42.31097
1
male
1
8
8
MOSF w/Malig
ARF/MOSF
1
16
under $11k
0
11,722
7,771.1914
9,862.02344
20.5
white
31.796875
53
0.419983
0.300964
3
0
0
metastatic
0
0
dnr after sadm
3
118
22
113
25
35.5
165
3.099609
1.199951
11.699219
141
7.389648
145
111
4
0
2
<2 mo. follow-up
2
7,518
72.60498
1
female
0
3
29
Lung Cancer
Cancer
3
8
under $11k
0
1,733
1,235.1172
1,652.92969
null
white
31.699219
17
0.294983
0.047997
1
1
0
metastatic
0.1
0
dnr before sadm
-1
99
4.699219
76
20
37.89844
null
4.699219
1
0.899902
141
null
97
14
null
null
null
<2 mo. follow-up
3.372559
7,519
48.27399
1
female
1
45
45
Coma
Coma
0
10
$25-$50k
94
91,330
60,467.9062
69,929.5
44
white
24.5
49
0.390991
0.316956
1
0
0
no
0.5
0.5
dnr after sadm
31
60
12.699219
64
30
38.5
134
2.699707
0.799927
0.599976
140
7.5
104
5
2,444
null
0
<2 mo. follow-up
0
7,520
65.40698
0
female
0
32
518
Coma
Coma
1
12
under $11k
44
75,896
51,033.0938
59,645.875
29
white
18.898438
9
0.523926
0.452942
14
0
1
no
0.65
0.65
no dnr
32
77
10
68
28
36.39844
null
null
1
1.199951
136
null
369
26
null
null
4
adl>=4 (>=5 if sur)
4
7,521
54.31097
0
female
0
4
517
CHF
COPD/CHF/Cirrhosis
6
8
$11-$25k
0
4,114
2,559.4043
3,203.91992
15
white
23
20
0.860962
0.769897
1
1
0
no
0.5
0.4
no dnr
4
144
13.398438
65
36
39.19531
178
3.299805
0.899902
1.599854
133
7.469727
184
16
2,137
2
null
SIP>=30
1.838867
7,522
61.03198
0
female
0
3
516
CHF
COPD/CHF/Cirrhosis
3
12
$11-$25k
0
4,608
2,287.1426
2,884.43945
null
white
15.398438
16
0.886963
0.81189
1
0
0
yes
0.4
0.3
no dnr
3
121
19.597656
144
48
38.39844
197.9375
2.799805
0.799927
2.799805
142
7.419922
170
39
2,525
null
null
no(M2 and SIP pres)
2.261231
7,523
45.55499
1
male
0
9
320
Cirrhosis
COPD/CHF/Cirrhosis
2
11
under $11k
0
16,900
10,686.7422
12,602.9297
29
white
27.597656
47
0.754883
0.611938
1
0
0
no
0.85
0.75
no dnr
9
113
7.099609
96
24
35.29688
null
2.899902
0.599976
2.299805
137
null
66
35
3,550
0
null
null
0.494751
7,524
76.41595
0
male
0
6
513
CHF
COPD/CHF/Cirrhosis
2
12
under $11k
0
17,222
9,349.5156
11,712.0156
27
hispanic
19.699219
6
0.787964
0.660889
1
0
0
yes
0.95
0.9
no dnr
6
66
9.5
78
26
36
212.875
3.099609
0.899902
1.399902
131
7.40918
137
33
2,581
1
0
SIP>=30
0
7,525
55.73999
1
male
0
5
46
CHF
COPD/CHF/Cirrhosis
3
12
under $11k
0
4,888
3,340.1641
3,512.76953
7
white
27.296875
36
0.802979
0.682983
1
0
0
no
0.9
0.8
no dnr
5
81
5.399414
68
18
37
null
3.199707
0.399963
4.299805
141
null
81
60
null
0
null
<2 mo. follow-up
0.494751
7,526
49.008
0
female
0
4
509
CHF
COPD/CHF/Cirrhosis
4
16
under $11k
0
3,640
2,666.0059
2,941.5293
11
black
10.898438
19
0.950928
0.916992
1
0
0
no
0.7
0.5
no dnr
4
109
10.898438
111
40
37.69531
142.5
null
null
0.899902
135
7.389648
131
6
883
1
null
SIP>=30
1.166748
7,527
31.55399
0
female
0
22
507
ARF/MOSF w/Sepsis
ARF/MOSF
3
12
$11-$25k
0
38,997
25,602.6406
28,688.6094
19.333328
hispanic
30.5
37
0.827881
0.768921
1
1
0
no
0.9
0.9
no dnr
22
63
200
156
32
39.09375
null
3.199707
0.899902
1.199951
140
null
101
9
4,600
2
0
SIP>=30
0
7,528
56.616
0
male
0
12
507
Cirrhosis
COPD/CHF/Cirrhosis
3
18
$25-$50k
0
19,741
12,691.1953
14,891.0391
24.5
white
17.796875
26
0.837891
0.734985
1
0
0
no
0.75
0.65
no dnr
12
157
17.796875
179
41
39.59375
215
3.399902
0.699951
1.299805
133
7.519531
315
18
1,264
1
1
null
1
7,529
66.78699
0
female
0
13
507
MOSF w/Malig
ARF/MOSF
1
10
under $11k
9
26,886
18,592.5
22,514.9531
17.5
black
28.398438
52
0.367981
0.25
10
0
0
metastatic
0.5
0.4
dnr before sadm
-4
105
11.099609
60
20
38.29688
null
3.399902
0.5
1.599854
137
null
463
29
null
null
7
null
7
7,530
74.13599
0
female
0
44
507
COPD
COPD/CHF/Cirrhosis
6
4
under $11k
9
71,806
47,299.75
51,366.7812
23.25
black
27.597656
52
0.655884
0.478943
1
1
0
no
0.95
0.9
no dnr
44
121
19.796875
63
64
35.5
288
2.399902
1.699951
0.799927
141
7.469727
257
12
5,725
5
0
adl>=4 (>=5 if sur)
0
7,531
30.39
1
male
0
6
26
Cirrhosis
COPD/CHF/Cirrhosis
1
11
under $11k
0
6,106
4,069.7422
5,218.54688
10
white
28.796875
35
0.821899
0.709961
1
0
0
no
1
0.9
no dnr
6
85
8.599609
92
20
37.39844
null
2.399902
1.599854
0.899902
132
null
100
12
null
1
0
<2 mo. follow-up
0
7,532
26.35999
0
female
0
48
506
COPD
COPD/CHF/Cirrhosis
4
11
under $11k
0
95,201
59,971.8125
67,958.5
25.25
black
19.796875
19
0.962891
0.93689
1
0
0
no
0.85
0.7
no dnr
48
97
4.799805
100
28
36.79688
91.42188
3.699707
0.599976
0.799927
134
7.369141
162
10
2,100
null
4
SIP>=30
4
7,533
43.03897
1
female
0
7
227
MOSF w/Malig
ARF/MOSF
2
10
under $11k
37
48,817
31,306.2031
35,121.6875
19.5
black
25.398438
45
0.426941
0.306946
19
0
0
yes
0.55
0.5
no dnr
7
101
6.799805
96
16
36
null
3.099609
0.799927
1.099854
135
null
80
27
2,050
null
0
no(M2 and SIP pres)
0
7,534
79.02496
1
female
0
5
83
Lung Cancer
Cancer
2
12
under $11k
9
5,753
3,172.6074
3,622.81836
8
white
24.796875
19
0.427979
0.121994
1
0
0
metastatic
0.35
0.05
dnr after sadm
2
71
18.398438
80
20
36
308.6875
null
null
1.199951
140
7.439453
108
23
null
5
5
SIP>=30
5
7,535
23.11299
0
male
0
43
503
Coma
Coma
0
12
under $11k
61
104,075
66,718.4375
77,519.875
35.5
black
23.5
35
0.740967
0.692993
3
0
0
no
0.05
0.02
no dnr
43
107
11.798828
76
24
37.89844
null
3.599609
0.5
3.099609
135
null
104
33
5,300
null
0
adl>=4 (>=5 if sur)
0
7,536
44.42999
0
male
0
5
503
CHF
COPD/CHF/Cirrhosis
3
12
$25-$50k
0
3,720
2,596.6738
2,879.49805
13
black
17.398438
9
0.92688
0.875977
1
1
0
no
0.99
0.9
no dnr
5
113
7.299805
104
24
39.59375
null
2.899902
0.5
0.799927
134
null
379
4
3,700
0
0
no(M2 and SIP pres)
0
7,537
64.12
0
male
0
18
503
CHF
COPD/CHF/Cirrhosis
7
12
$11-$25k
0
40,679
21,071.2031
25,232.2188
20.666656
white
35.398438
73
0.545898
0.347961
4
1
0
no
0.05
0.01
dnr after sadm
14
125
3.899902
72
22
36.29688
309.5
null
null
1.199951
146
7.429688
108
27
2,075
0
1
no(M2 and SIP pres)
1
7,538
54.19299
1
male
0
10
55
COPD
COPD/CHF/Cirrhosis
3
11
under $11k
0
12,546
7,809.6836
8,627.97656
13
white
16.097656
13
0.929932
0.880981
1
0
0
no
0.95
0.9
no dnr
10
80
4.899414
50
22
36.19531
null
3.599609
0.899902
1.5
152
null
94
16
1,695
3
4
<2 mo. follow-up
4
7,539
18.77599
0
male
0
12
501
ARF/MOSF w/Sepsis
ARF/MOSF
0
12
$25-$50k
0
31,368
19,824.9375
22,587.9688
41.5
white
29.898438
33
0.86792
0.821899
1
0
0
no
0.65
0.6
no dnr
12
94
17.097656
100
32
37.89844
46.66406
3.399902
1.099854
1.699951
142
7.549805
125
42
795
0
0
no(M2 and SIP pres)
0
7,540
72.97998
0
female
0
10
501
ARF/MOSF w/Sepsis
ARF/MOSF
3
8
under $11k
9
13,111
7,897.5391
8,604.72656
16.5
white
18.597656
25
0.831909
0.775879
1
1
0
no
0.5
0.2
dnr after sadm
3
81
8.5
58
20
36.19531
null
4.199219
1
1.199951
137
null
84
12
null
null
1
adl>=4 (>=5 if sur)
1
7,541
70.43695
1
female
1
7
7
Coma
Coma
3
null
under $11k
44
30,399
19,896.4531
22,794.8281
25.5
black
33.195313
73
0.093994
0.056
13
1
0
no
0.1
0.05
dnr after sadm
1
109
6.5
74
20
36.09375
null
3.099609
6.599609
1
134
null
109
11
null
null
6
<2 mo. follow-up
6
7,542
67.86597
1
male
1
32
32
CHF
COPD/CHF/Cirrhosis
4
8
under $11k
37
61,337
39,699.4375
44,266.5938
20.25
white
18.199219
37
0.776978
0.643921
2
1
0
no
0.8
0.8
no dnr
32
153
4.699219
54
38
37.89844
319
3.199707
0.5
0.899902
142
7.459961
107
7
3,154
null
0
<2 mo. follow-up
0
7,543
25.54099
0
male
0
9
498
ARF/MOSF w/Sepsis
ARF/MOSF
0
14
under $11k
0
14,621
9,416.0859
10,230.5234
17
asian
28.398438
29
0.866943
0.820923
1
0
0
no
0.95
0.95
no dnr
9
121
20
60
24
36.69531
392
2.899902
0.399963
3.899902
137
7.399414
376
57
null
0
null
null
0.494751
7,544
67.61896
1
male
0
41
58
ARF/MOSF w/Sepsis
ARF/MOSF
2
16
$25-$50k
0
114,873
74,604.5625
85,581.0625
37
white
26
43
0.559937
0.447998
12
0
0
metastatic
0.4
0.3
no dnr
41
69
2.399902
66
20
34.5
280.9375
3.299805
0.799927
0.799927
141
7.55957
166
11
null
null
0
<2 mo. follow-up
0
7,545
44.09299
0
male
0
5
496
Lung Cancer
Cancer
3
12
under $11k
0
3,904
2,738.0293
3,507.14844
13
black
11.5
11
0.834961
0.638916
1
0
0
metastatic
0.75
0.6
no dnr
5
124
6.399414
146
36
35.69531
261.875
2.299805
2.799805
6.899414
143
7.209961
54
40
2,036
0
null
no(M2 and SIP pres)
0.494751
7,546
33.741
0
male
0
28
494
ARF/MOSF w/Sepsis
ARF/MOSF
3
10
under $11k
0
88,800
58,121.7188
72,872.375
43.5
white
30.796875
47
0.779907
0.708984
5
0
0
no
0.8
0.7
no dnr
28
119
14.599609
131
33
40.09375
131.09375
null
null
1.599854
151
7.479492
180
26
2,735
null
0
no(M2 and SIP pres)
0
7,547
49.09
0
female
0
8
493
ARF/MOSF w/Sepsis
ARF/MOSF
1
14
under $11k
0
10,245
6,872.3477
7,327.44922
9
white
35.195313
22
0.67688
0.581909
1
0
0
no
0.9
0.75
no dnr
8
76
33.195313
124
10
38.79688
86.65625
1.899902
4.399414
1
143
7.459961
89
17
4,050
0
null
no(M2 and SIP pres)
0.494751
7,548
63.88797
0
male
0
75
492
COPD
COPD/CHF/Cirrhosis
4
null
under $11k
0
187,289
113,972.438
129,011.125
30.75
white
20.199219
30
0.844971
0.744995
4
0
0
no
0.85
0.8
no dnr
75
100
4.799805
72
16
36.09375
504.75
5.199219
5.299805
1.099854
135
7.439453
155
13
4,150
null
0
adl>=4 (>=5 if sur)
0
7,549
73.88599
1
female
1
12
12
ARF/MOSF w/Sepsis
ARF/MOSF
0
12
null
0
81,752
51,140.0625
62,188
64.5
white
39.195313
80
0.344971
0.228973
5
0
0
no
0
0
dnr after sadm
12
167
8.898438
122
10
38.09375
200
1.5
8.599609
0.799927
137
7.189453
197
27
1,548
null
1
<2 mo. follow-up
1
7,550
32.65198
0
male
0
18
491
ARF/MOSF w/Sepsis
ARF/MOSF
0
12
under $11k
0
23,825
15,030.7344
16,773.9375
19.333328
white
27.199219
29
0.861938
0.813965
1
0
0
no
0.85
0.8
no dnr
18
155
10.699219
72
32
39.19531
370
3.199707
0.899902
3
142
7.40918
126
32
1,715
4
null
no(M2 and SIP pres)
3.183106
7,551
92.65399
1
female
1
8
8
Coma
Coma
1
null
under $11k
55
33,577
21,423.25
25,377.0156
39
white
17.796875
30
0.233978
0.168976
10
1
0
no
0
0
dnr after sadm
6
53
5.5
78
10
39
124
3.699707
0.599976
1.399902
130
7.279297
225
29
2,125
null
1
<2 mo. follow-up
1
7,552
33.46997
0
male
0
4
490
CHF
COPD/CHF/Cirrhosis
1
12
$11-$25k
0
3,483
2,353.5195
2,468.35938
11
white
15.699219
6
0.948975
0.912964
1
0
0
no
0.8
0.7
no dnr
4
124
12.5
116
24
38.59375
276.625
3
0.5
1.099854
143
7.429688
135
20
1,288
0
0
no(M2 and SIP pres)
0
7,553
39.62198
0
male
0
47
489
ARF/MOSF w/Sepsis
ARF/MOSF
1
null
under $11k
0
99,971
62,746.625
70,309.1875
33
black
22.699219
46
0.888916
0.848999
1
0
0
no
0.75
0.7
no dnr
47
99
7.299805
120
24
36.59375
212.5
null
null
2.299805
139
7.389648
90
10
1,400
null
6
adl>=4 (>=5 if sur)
6
7,554
74.39294
1
female
0
11
16
Lung Cancer
Cancer
1
15
under $11k
0
13,282
8,855.1875
11,715.9297
17.5
white
28.5
23
0.380981
0.091995
1
0
0
metastatic
0.6
0.2
dnr after sadm
1
73
7.599609
64
24
35.59375
442.8125
2.799805
1.899902
1.099854
136
7.509766
73
26
2,375
0
2
<2 mo. follow-up
2
7,555
60.51199
0
female
0
6
488
CHF
COPD/CHF/Cirrhosis
0
8
$11-$25k
0
5,472
3,706.3887
3,897.24805
12
black
13.599609
14
0.922974
0.869995
1
0
0
no
0.8
0.6
no dnr
6
63
5.799805
152
16
39.09375
null
2.599609
3.899902
0.799927
127
null
94
6
1,450
0
null
no(M2 and SIP pres)
0.494751
7,556
68.12
1
male
1
25
25
Cirrhosis
COPD/CHF/Cirrhosis
1
18
under $11k
9
25,188
17,244.2031
19,472.0156
7.5
white
33.5
59
0.359985
0.167999
1
0
0
no
0.9
0.7
dnr after sadm
17
108
6.899414
96
22
35.39844
null
2.599609
4.799805
0.5
126
null
94
1
null
0
null
<2 mo. follow-up
0.494751
7,557
60.04398
1
male
0
6
169
ARF/MOSF w/Sepsis
ARF/MOSF
3
14
under $11k
0
15,198
10,064.9766
10,894.9453
41
white
23.898438
52
0.824951
0.765991
1
1
0
no
0.9
0.9
no dnr
6
136
11.798828
133
36
36.5
125
2.099609
0.399963
3.799805
139
7.329102
120
72
1,237
0
0
no(M2 and SIP pres)
0
7,558
70.56799
0
male
0
9
481
COPD
COPD/CHF/Cirrhosis
4
9
under $11k
0
12,137
6,805.6562
7,839.60938
15
white
21.5
27
0.776978
0.643921
1
0
0
yes
0.9
0.8
no dnr
9
69
8.798828
80
20
36.79688
null
3.599609
1.199951
1.299805
143
null
65
33
850
1
0
adl>=4 (>=5 if sur)
0
7,559
50.543
1
female
0
21
39
MOSF w/Malig
ARF/MOSF
2
3
$25-$50k
9
50,746
34,318.1875
41,470.5
29.666656
white
32
41
0.385986
0.266968
9
0
0
yes
0.75
0.6
no dnr
21
66
6.299805
109
25
36.29688
202.21875
2.699707
1
1.099854
132
7.389648
126
33
1,115
7
7
<2 mo. follow-up
7
7,560
72.50696
1
male
0
6
119
CHF
COPD/CHF/Cirrhosis
1
0
under $11k
0
14,569
7,082.6367
8,828.42969
20
white
23.199219
28
0.770996
0.634888
3
0
0
no
0.8
0.7
no dnr
6
116
14.099609
147
26
36.79688
328.5625
4
0.699951
1
135
7.469727
109
16
1,750
null
null
null
3.085449
7,561
66.672
1
male
0
22
183
ARF/MOSF w/Sepsis
ARF/MOSF
2
14
$11-$25k
0
29,171
18,045.1094
22,454.75
19.333328
black
19.5
29
0.85791
0.80896
1
1
0
no
0.9
0.8
no dnr
22
77
6.299805
77
20
36.19531
404.75
4.299805
1.099854
2.099609
134
7.399414
100
16
null
0
0
no(M2 and SIP pres)
0
7,562
61.13898
1
male
0
8
283
Coma
Coma
0
null
under $11k
44
7,577
5,176.9258
5,870.35938
11
black
24.097656
30
0.529907
0.459961
1
0
0
no
0.6
0.5
no dnr
8
60
18
74
10
36.39844
63
1.299805
2.599609
2.799805
146
7.319336
97
56
992
null
7
adl>=4 (>=5 if sur)
7
7,563
69.36896
0
female
0
13
484
Cirrhosis
COPD/CHF/Cirrhosis
2
12
under $11k
9
14,009
9,544.2656
10,667.0859
17.5
white
27.398438
43
0.525879
0.325989
1
0
0
no
0.5
0.4
dnr after sadm
1
109
14.699219
125
22
36.5
353.3125
1.799805
0.5
1.5
132
7.369141
107
12
3,120
6
4
null
4
7,564
72.96594
1
male
0
18
49
Colon Cancer
Cancer
1
19
$25-$50k
0
26,584
19,455.9688
28,796.6562
23
white
33.5
49
0.429993
0.122986
1
0
0
metastatic
0.75
0.6
dnr after sadm
17
137
10
122
12
38.09375
240
1.899902
1.199951
0.899902
149
7.539062
194
27
1,232
0
0
<2 mo. follow-up
0
7,565
68.54797
0
male
0
95
481
COPD
COPD/CHF/Cirrhosis
4
null
null
37
197,417
126,041.625
151,807.5
55.25
white
38.898438
42
0.228973
0.075989
3
0
0
no
null
null
no dnr
95
61
104
176
26
39.29688
105
2.199707
2.399902
2.899902
141
7.319336
376
70
1,113
null
null
Coma or Intub
5.333008
7,566
79.12396
1
female
1
3
3
ARF/MOSF w/Sepsis
ARF/MOSF
4
null
under $11k
100
18,622
11,870.8281
13,468.7656
null
black
82.390625
113
0
0
5
1
0
no
null
null
no dnr
3
66
6.699219
50
30
35
404.0625
2.099609
0.599976
2.699707
136
7.279297
81
108
337
null
null
<2 mo. follow-up
2.645996
7,567
62.883
0
female
0
4
480
COPD
COPD/CHF/Cirrhosis
2
null
under $11k
0
3,748
2,488.6074
2,575.55859
7
white
15
14
0.91394
0.85498
1
0
0
no
0.5
0.4
no dnr
4
71
21.699219
109
26
38.29688
134.6875
2
0.799927
1.599854
134
7.429688
100
30
5,752
0
null
SIP>=30
0.494751
7,568
78.31897
0
female
0
9
480
COPD
COPD/CHF/Cirrhosis
2
null
under $11k
0
12,338
7,648.0586
8,438.74219
20.5
white
21.398438
55
0.771973
0.636963
1
0
0
no
0.5
0.25
dnr after sadm
1
60
9.5
118
40
36.19531
285.6875
2.399902
2.199707
1.399902
130
7.379883
124
50
966
null
5
adl>=4 (>=5 if sur)
5
7,569
69.21295
1
male
0
3
118
Lung Cancer
Cancer
2
16
$11-$25k
0
3,566
2,432.3281
2,913.5293
null
white
21.699219
9
0.589966
0.270996
1
0
0
metastatic
null
null
no dnr
3
99
6
72
20
35.79688
null
3.199707
1.399902
1
138
null
331
13
2,600
null
null
no(M2 and SIP pres)
2.800293
7,570
58.76797
0
male
0
5
479
Coma
Coma
1
12
$11-$25k
55
14,700
8,925.7891
10,656.9844
29
black
20
34
0.606934
0.542969
1
1
0
no
0.4
0.4
no dnr
5
109
4.699219
64
20
36.09375
null
3.899902
0.699951
1.599854
140
null
153
22
1,700
null
0
adl>=4 (>=5 if sur)
0
7,571
38.11899
0
female
0
16
479
ARF/MOSF w/Sepsis
ARF/MOSF
1
8
under $11k
9
47,093
28,861.0938
33,175.9375
30.333328
white
27.5
25
0.782959
0.711914
1
0
0
yes
0.9
0.9
no dnr
16
133
19.5
133
36
36.19531
223.0625
3.099609
0.899902
0.5
141
7.389648
161
9
1,425
null
0
no(M2 and SIP pres)
0
7,572
66.91296
1
female
1
26
26
COPD
COPD/CHF/Cirrhosis
3
12
$11-$25k
0
86,018
52,848.6875
61,411.9688
32.25
white
23.5
32
0.790894
0.66394
3
0
0
no
0.9
0.8
no dnr
26
103
7.599609
80
24
35.89844
220
3.699707
0.299988
1
132
7.399414
139
16
1,850
null
0
<2 mo. follow-up
0
7,573
36.80798
0
male
0
9
476
ARF/MOSF w/Sepsis
ARF/MOSF
4
12
under $11k
41
29,838
18,833.5156
21,812.75
35
white
32.398438
47
0.642944
0.542969
1
0
0
no
0.5
0.4
no dnr
9
69
15.5
67
10
35.69531
502
1.899902
1.799805
0.699951
136
7.419922
182
13
1,915
null
0
no(M2 and SIP pres)
0
7,574
76.57996
1
male
1
7
7
Coma
Coma
2
10
$11-$25k
61
16,563
10,596.4062
12,530.3438
32
white
24
41
0.28595
0.215973
1
1
0
no
0.3
0.2
dnr after sadm
3
69
11.599609
171
55
38.79688
142.5
2.799805
0.899902
1.399902
144
7.519531
107
17
1,092
null
0
<2 mo. follow-up
0
7,575
71.24396
0
female
0
35
474
MOSF w/Malig
ARF/MOSF
4
12
under $11k
0
108,652
71,450.875
79,561.625
23.25
white
22.796875
37
0.536987
0.422974
31
0
0
metastatic
0
0
dnr after sadm
2
126
6.399414
134
32
38
106.65625
2.199707
11.199219
0.899902
128
7.549805
134
5
575
null
2
null
2
7,576
67.25
0
male
0
3
473
CHF
COPD/CHF/Cirrhosis
4
14
null
0
2,763
1,765.1641
2,354.55859
null
white
21.5
28
0.838989
0.735962
1
0
0
no
null
null
no dnr
3
69
24
126
22
36.69531
220
null
0.599976
1.199951
137
7.369141
160
40
1,560
null
null
no(M2 and SIP pres)
2.708984
7,577
52.698
0
female
0
9
472
COPD
COPD/CHF/Cirrhosis
2
9
under $11k
0
21,141
12,759.8672
14,685.0781
33.5
white
27.597656
39
0.837891
0.734985
1
0
0
no
null
null
no dnr
9
127
16.296875
107
24
38.19531
288
2.599609
1
2.099609
140
7.329102
81
63
3,993
null
3
no(M2 and SIP pres)
3
7,578
52.00497
1
male
1
7
7
Coma
Coma
1
8
$11-$25k
44
14,741
9,165.6875
10,467.9062
17
white
16.699219
29
0.763916
0.719971
1
0
0
no
0.4
0.35
dnr after sadm
4
0
11
150
31
38.79688
297.5
1.799805
4.199219
3.699707
125
7.379883
42
66
5,930
null
0
<2 mo. follow-up
0
7,579
59.89297
0
female
0
4
468
CHF
COPD/CHF/Cirrhosis
4
null
null
0
3,672
2,393.9316
2,511.20898
6
black
14.5
17
0.917969
0.861938
1
1
0
no
0.95
0.95
no dnr
4
135
14.898438
105
5
38.39844
356.625
null
null
0.699951
131
7.479492
144
13
1,618
null
null
null
3.274902
7,580
57.98499
1
female
0
5
415
COPD
COPD/CHF/Cirrhosis
6
12
$11-$25k
0
7,687
4,499.8242
5,196.07812
22
white
16.898438
32
0.892944
0.820923
1
1
0
yes
0.9
0.6
no dnr
5
120
3.799805
77
20
37
null
3.299805
1
1
134
null
176
10
null
0
1
null
1
7,581
72.31494
0
female
0
8
468
CHF
COPD/CHF/Cirrhosis
3
10
$11-$25k
0
17,686
10,106.5
12,971.2031
14.5
white
12.599609
18
0.908936
0.845947
1
1
0
no
0.99
0.9
no dnr
8
64
4.5
111
8
38.19531
523.75
2.599609
0.399963
0.599976
137
7.429688
83
10
4,105
0
0
no(M2 and SIP pres)
0
7,582
54.32397
0
male
0
9
466
COPD
COPD/CHF/Cirrhosis
5
12
under $11k
0
12,159
7,667.8555
8,439.94531
15.5
black
20.296875
41
0.901978
0.835938
1
0
0
no
0.8
0.75
dnr after sadm
6
110
3.5
122
28
37.89844
null
2.699707
0.399963
1.5
133
null
112
30
1,275
1
4
SIP>=30
4
7,583
60.30698
1
male
1
14
14
MOSF w/Malig
ARF/MOSF
4
12
under $11k
26
63,465
39,629.4688
49,235.625
38.333313
white
33.796875
65
0.232971
0.132996
8
0
0
yes
0.7
0.7
dnr after sadm
7
83
0.699951
101
20
35.79688
null
3.599609
0.599976
1.299805
133
null
108
18
null
6
2
<2 mo. follow-up
2
7,584
63.258
1
male
1
51
51
ARF/MOSF w/Sepsis
ARF/MOSF
3
12
under $11k
37
128,478
79,063.25
91,306.6875
37.75
white
22
36
0.545898
0.432983
6
1
0
metastatic
0.5
0.4
dnr after sadm
51
140
15.099609
150
25
38.69531
314
null
null
1.199951
149
7.429688
163
31
3,680
null
3
<2 mo. follow-up
3
7,585
65.01599
1
male
1
10
10
MOSF w/Malig
ARF/MOSF
1
10
under $11k
9
31,724
20,273.4844
25,110.5781
40
white
32.5
57
0.440979
0.32196
1
0
0
yes
0.2
0
dnr after sadm
7
69
0.799927
146
24
36.39844
null
2
1
0.699951
131
null
117
11
5,050
null
1
<2 mo. follow-up
1
7,586
32.12299
0
female
0
6
463
COPD
COPD/CHF/Cirrhosis
3
12
under $11k
0
6,625
4,011.2188
4,399.70703
12
white
22.398438
28
0.944946
0.905884
1
0
0
no
1
0.75
no dnr
6
90
10.699219
76
20
35.89844
null
2.299805
0.5
1
131
null
127
17
null
0
null
null
0.494751
7,587
73.98999
0
female
0
5
463
Colon Cancer
Cancer
1
12
$11-$25k
9
4,497
3,107.4102
4,095.87891
13
white
27.898438
20
0.53894
0.21698
1
0
0
metastatic
0.5
0.2
dnr after sadm
3
120
17.597656
71
26
38.69531
190
2.699707
0.799927
5.599609
144
7.319336
99
65
1,517
1
1
no(M2 and SIP pres)
1
7,588
75.98395
0
male
0
21
463
ARF/MOSF w/Sepsis
ARF/MOSF
4
8
under $11k
44
40,937
27,263.9688
32,782.125
30
black
29.796875
58
0.387939
0.268982
4
0
0
no
0.5
0.5
no dnr
21
118
9.599609
55
10
37.69531
363.3125
null
null
0.5
134
7.419922
120
11
2,285
null
7
adl>=4 (>=5 if sur)
7
7,589
64.26599
0
female
0
5
461
COPD
COPD/CHF/Cirrhosis
2
6
under $11k
0
10,697
6,611.6211
8,725.60938
15
white
23.097656
24
0.833984
0.727905
1
1
0
no
1
1
no dnr
5
76
9.798828
130
20
36.5
200
3.299805
1.099854
1
137
7.449219
102
18
null
1
1
no(M2 and SIP pres)
1
7,590
67.95898
0
male
0
3
461
COPD
COPD/CHF/Cirrhosis
2
12
$11-$25k
0
2,667
1,682.0225
1,844.41992
null
white
14.898438
10
0.898926
0.830933
1
0
0
no
1
0.9
no dnr
3
90
10.199219
116
20
36.29688
null
3.599609
0.399963
1.099854
136
null
106
17
1,700
0
0
no(M2 and SIP pres)
0
7,591
57.383
0
male
0
3
461
CHF
COPD/CHF/Cirrhosis
1
15
under $11k
0
9,595
5,629.1094
7,239.08984
14
white
14.798828
23
0.920898
0.865967
1
0
0
no
0.95
0.9
no dnr
3
131
5.899414
53
38
38.59375
158
2.599609
7
0.799927
137
7.399414
176
28
1,868
0
0
SIP>=30
0
7,592
65.51398
0
male
0
15
460
Cirrhosis
COPD/CHF/Cirrhosis
3
12
null
0
89,647
58,617.6562
66,263.625
26.666656
white
36.398438
64
0.215973
0.068985
37
0
0
no
0.3
0.3
no dnr
15
110
16.398438
71
22
36.19531
172
null
0.5
0.899902
138
7.269531
97
13
2,190
null
0
no(M2 and SIP pres)
0
7,593
76.72296
1
female
0
6
245
MOSF w/Malig
ARF/MOSF
1
8
under $11k
0
8,117
5,389.4609
6,440.42969
20
black
26.398438
26
0.552979
0.438965
1
0
0
metastatic
0.8
0.5
no dnr
6
99
8.298828
106
16
35.5
500
3.439941
5.299805
1.399902
130
7.509766
51
42
null
0
0
no(M2 and SIP pres)
0
7,594
60.76398
1
female
0
88
89
ARF/MOSF w/Sepsis
ARF/MOSF
2
1
under $11k
9
192,117
117,801.75
129,911.562
42.5
white
21.5
22
0.832886
0.776978
1
0
0
no
0.7
0.75
dnr after sadm
14
101
10.099609
72
24
36.59375
null
4.299805
0.599976
1.5
138
null
107
17
1,925
null
0
adl>=4 (>=5 if sur)
0
7,595
75.92297
1
male
1
47
47
ARF/MOSF w/Sepsis
ARF/MOSF
1
11
null
0
210,541
138,336.5
174,062
49
white
25.398438
66
0.648926
0.549927
38
0
0
no
0.1
0.05
dnr after sadm
45
128
16
78
32
36.59375
228.5625
3
1
1.299805
114
7.379883
188
19
4,805
null
0
<2 mo. follow-up
0
7,596
24.69299
0
male
0
24
455
ARF/MOSF w/Sepsis
ARF/MOSF
1
10
under $11k
0
155,743
101,314.812
127,360.25
28.333328
white
22.5
35
0.848999
0.795898
68
0
0
yes
0.9
0.9
no dnr
24
126
3
77
28
38
267.8125
2.599609
5
0.899902
136
7.439453
85
13
2,975
0
0
null
0
7,597
57.24799
0
female
0
5
455
Colon Cancer
Cancer
1
13
null
0
6,553
4,324.3398
4,882.61719
7
white
12.099609
3
0.882935
0.734985
1
0
0
metastatic
1
0.9
no dnr
5
99
0.699951
120
40
38.29688
null
2.099609
1.199951
0.899902
137
null
164
7
1,600
0
null
no(M2 and SIP pres)
0.494751
7,598
72.19995
1
male
1
9
9
MOSF w/Malig
ARF/MOSF
2
16
under $11k
9
44,016
30,163.4062
38,612.875
27.5
white
25.097656
31
0.517944
0.40094
20
0
1
yes
0.5
0.5
dnr before sadm
-9
117
4.199219
60
22
36.29688
196
2.099609
0.199982
2.299805
138
7.319336
117
62
1,150
null
7
<2 mo. follow-up
7
7,599
40.06598
0
male
0
48
453
ARF/MOSF w/Sepsis
ARF/MOSF
1
12
under $11k
0
159,555
98,485.4375
113,089.188
43
white
29.5
62
0.812988
0.750977
1
1
0
no
0.8
0.8
no dnr
48
71
17.898438
84
20
36.89844
null
2.399902
20.398438
1
127
null
70
13
null
null
7
SIP>=30
7
7,600
66.26398
1
male
0
5
114
COPD
COPD/CHF/Cirrhosis
3
8
under $11k
0
13,492
8,294.0156
9,444.0625
13
black
17.597656
25
0.785889
0.656982
4
1
0
metastatic
0.5
0.25
no dnr
5
69
10.298828
61
10
37.89844
190
3.099609
1.399902
1.099854
143
7.389648
118
11
4,375
0
0
no(M2 and SIP pres)
0